ZYME Financial Statements & Analysis
Complete financial statements for ZYME including income statement, balance sheet, and cash flow statement. Analyze ZYME's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
38.9% ↑
Net Income
33.9% ↑
Gross Margin
0.0% ↓
Operating Margin
51.4% ↑
Balance Sheet
Current Ratio
62.1% ↑
Debt to Equity
24.5% ↓
Asset Turnover
85.6% ↑
Cash Flow
Operating Cash Flow
70.0% ↑
Net Cash Flow
72.7% ↑
Free Cash Flow
69.5% ↑
Cash Flow to Debt
69.6% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 76.30M | 105.97M | 38.9% | |
| Gross Profit | 76.30M | 105.97M | 38.9% | |
| Operating Income | -137.11M | -92.53M | 32.5% | |
| Net Income | -122.69M | -81.13M | 33.9% | |
| EPS | -1.62 | -1.08 | 33.3% | |
| EBITDA | -108.62M | -68.64M | 36.8% | |
| Gross Margin | 100.00% | 100.00% | 0.0% | |
| Operating Margin | -179.69% | -87.33% | 51.4% | |
| Net Income Margin | -160.80% | -76.56% | 52.4% | |
| R&D Expenses | 134.62M | 137.00M | 1.8% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 105.97M | 76.30M | 76.01M | — | — |
| Gross Profit | 105.97M | 76.30M | -66.98M | — | — |
| Operating Income | -92.53M | -137.11M | -138.05M | — | — |
| Net Income | -81.13M | -122.69M | -118.67M | — | — |
| EPS | -1.08 | -1.62 | -1.72 | — | — |
| EBITDA | -68.64M | -108.62M | -120.70M | — | — |
| Gross Margin | 100.00% | 100.00% | -88.11% | — | — |
| Operating Margin | -87.33% | -179.69% | -181.62% | — | — |
| Net Income Margin | -76.56% | -160.80% | -156.13% | — | — |
| R&D Expenses | 137.00M | 134.62M | 143.62M | — | — |
Financial Metrics
Want to dive deeper into ZYME's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics